MetaCap

Relmada Therapeutics Statistics

NASDAQ: RLMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.62-0.49 (-15.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Relmada Therapeutics by the numbers

Relmada Therapeutics has a market capitalization of $279.5 million based on 106.69M shares outstanding. With trailing EPS of $-0.73, Relmada Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.1% below its 50-day average and 51.0% below its 200-day average.

Average daily trading volume is 1.45M shares, or about $3.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RLMD valuation vs. peer median

RLMD compared with the median of 8 peer companies
MetricRLMDPeer medianDifference
Market cap$279.54M$282.20M-1%
Avg. volume1.45M546.98K+166%

Peer median across 8 companies: FULC, GLSI, BNTC, GALT, EVMN, VCRE, SPRY, EBS.

Valuation

Price and trading

Previous close
3.11
Open
3.07
Day range
2.60 – 3.13
52-week range
2.60 – 8.00
52-week change
-38.64%
Beta
—
Volume
2.25M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
279.54M
Forward Pe
-6.39
Eps
-0.73
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
8.00
Week52 Low
2.60
Avg Volume
1.45M
Shares Outstanding
106.69M
Ma50
3.64
Ma200
5.35
Earnings Date
Nov 12, 2026
Pct From52w High
-67.25%
Pct From52w Low
0.67%

Related